Brazil researchers ID substance that paves the way for visceral leishmaniasis treatments

A study shows that stimulating the production of interleukin-17A (IL-17A), one of the cytokines released by cells of the immune system, can be an effective strategy for the treatment of visceral leishmaniasis, considered one of the six most important parasitic diseases affecting humans. The principal investigator in this research is Joio Santana da Silva, Full ["]